Dermapharm Holding SE buy DirectorDealer
Summary
This prediction is currently active. Since the start of the prediction for Dermapharm Holding SE the price has only changed by 0.39%. This prediction currently runs until 07.01.27. The prediction end date can be changed by DirectorDealer at any time. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Dermapharm Holding SE | 0.39% |
| iShares Core DAX® | 2.462% |
| iShares Nasdaq 100 | 1.237% |
| iShares Nikkei 225® | 2.933% |
| iShares S&P 500 | 0.975% |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Dreibholz, Christof (Vorstand)
- Handelstag: 05.01.2026
- Volumen: 95825 €
- Meldende_r: Dreibholz, Christof


